Skip to content

Environmental Enteropathy Among Infants and Children With Growth Faltering

Prevalence of Environmental Enteropathy Among Infants and Children With Growth Faltering

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06497907
Enrollment
200
Registered
2024-07-12
Start date
2022-04-30
Completion date
2024-06-25
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteropathy, Growth Failure

Brief summary

The study was conducted on 200 patients with growth faltering on 2 phases. In the first phase the patient received nutritional rehabilitation with polymeric formula for 12 weeks then they were reassessed by anthropometric measurements and those whose weight remained below -2 SD for age and sex on the WHO scores were defined as non responders and entered the second phase. In the second phase Upper Gastrointestinal endoscopy was done and then patients received nutritional rehabilitation with peptide based formula and probiotics then were reassessed after 8 weeks.

Interventions

DIETARY_SUPPLEMENTpolymeric formula

Patients with growth faltering received nutritional rehabilitation with polymeric formula and were reassessed after 12 weeks by anthropometric measurements

DIETARY_SUPPLEMENTpeptide based formula

patients who were defined as non responders and underwent upper gastrointestinal endoscopy and diagnosed as environmental enteropathy, received nutritional rehabilitation with peptide based formula

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patient with growth faltering whose weight still below -2 SD for age and sex on the WHO scores after 12 weeks of nutritional rehabilitation with polymeric formula, underwent upper gastrointestinal endoscopy and who were diagnosed as environmental enteropathy, received nutritional rehabilitation with peptide based formula and probiotics

Eligibility

Sex/Gender
ALL
Age
6 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Patients whose weight below -2 SD for age and sex on the WHO scores.

Exclusion criteria

* Secondary cases of malnutrition or undernutrition. * Patients with symptoms of GIT problems as chronic vomiting, chronic or bloody diarrhea, chronic abdominal distension, hematemesis or bleeding per rectum. * Patients who can't commit to a follow up visit every two weeks.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the prevalence of environmental enteropathy among children with faltering growth.12 weeks of nutritional rehabilitation with polymeric formula.Assess the number of patients whose weight still below -2SD and upper gastrointestinal endoscopy showed the criteria of environmental enteropathy.

Secondary

MeasureTime frameDescription
Determine the increase in weight of children with growth faltering and environmental enteropathy after nutritional rehabilitation with peptide-based formula.8 weeks of nutritional rehabilitation with peptide-based formula.Weight z- score

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026